HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paradoxical hyperfixation of hexamethylpropyleneamine oxime in cerebral infarction.

Abstract
We describe four patients with cerebral infarction and 99mTc-hexamethylpropyleneamine oxime (HMPAO) hyperfixation in distributions corresponding to the infarctions seen at CT and/or MR imaging. Increased HMPAO extraction due to hyperpermeability across the blood-brain barrier and increased retention due to reduced back diffusion of the tracer probably accounted for the increased fractional fixation in infarcts seen in our patients.
AuthorsS Shintani, S Tsuruoka, T Shiigai
JournalAJNR. American journal of neuroradiology (AJNR Am J Neuroradiol) 1997 Nov-Dec Vol. 18 Issue 10 Pg. 1905-8 ISSN: 0195-6108 [Print] United States
PMID9403452 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Technetium Tc 99m Exametazime
Topics
  • Aged
  • Blood-Brain Barrier (physiology)
  • Brain Mapping
  • Cerebral Cortex (diagnostic imaging)
  • Cerebral Infarction (blood, diagnostic imaging)
  • Dominance, Cerebral (physiology)
  • Female
  • Humans
  • Male
  • Technetium Tc 99m Exametazime (pharmacokinetics)
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: